Michael Chin | Worcester, MA
Michael Chin, from Worcester, Massachusetts, graduated from the University of Virginia in 2002 with a dual Bachelor of Arts degree in Psychology and East Asian studies. During his time at Virginia, Michael became a research assistant at the Department of Radiation Oncology and the Brigham and Women’s Hospital in Boston, MA. There, Michael participated in retrospective studies on radiation treatment outcomes for Hodgkin’s disease patients. He also conducted a detailed analysis on a subgroup of patients with Lymphocyte-Predominant Hodgkin’s Disease.
Coming out of Virginia, Michael decided he wanted to pursue a medical career, so he applied and go into Tuft University’s post-baccalaureate premedical program. This program is a one-year intensive medical program that gives students the credits they need to apply to medical school. After completing this program, Michael attended Tufts University School of Medicine to obtain his MD. In his pursuit for his medical degree, Michael held multiple research positions. In 2007, he started off as a research assistant at Baystate Plastic Surgery where he conducted a retrospective study on the results of mastopexy and reduction mammoplasty after breast conserving therapy with radiation. After his research was complete at Baystate, Michael Chin went back to the Brigham and Women’s Hospital in Boston where he was a research associate for the Division of Plastic Surgery. There, he conducted studies in wound healing with special emphasis on the role of mechanical stress in cellular proliferation, angiogenesis and neuropeptide expression as well as established radiation wound and hypertrophic scar models in mice. During his fourth year at medical school, Michael was a jack-of-all-trades. He was a manuscript reviewer for Tissue Engineering and FASEB Journal, and his responsibilities included peer reviewing manuscript submissions for these basic science journals. He also received his medical degree with Research Honors distinction while winning multiple awards for his research in plastic surgery.
Michael Chin in Worcester, Massachusetts:
After medical school, Michael Chin moved to Worcester for his residency at the University of Massachusetts Medical School as a plastic surgery resident. During his first year of residency, Michael was a manuscript reviewer for Burns and Wound Repair and Regeneration journals. He also began to co-investigate at the University of Massachusetts and Brigham and Women’s Hospital. At Brigham, Michael designed and conducted IRB-approved outcomes research on post-mastectomy reconstruction patients who have previously undergone breast-conserving therapy with radiation. At UMass, he built a strong research team that conducted privately funded studies to examine the effects and possible mitigation of radiation induced skin injury in irradiated mice. During his third year of residency, Michael became a co-investigator at the Department of Radiation Oncology at the University of Massachusetts. There, he designed and conducted IRB-approved clinical study evaluating the use of hyperspectral imaging assessment in irradiated breast cancer patients. By the end of his third year at UMass, Michael was appointed to a faculty position as Instructor of Radiation Oncology. Michael’s work in hyperspectral imaging resulted in a patent filing for a novel method of radiation exposure detection.
In 2013, Michael Chin began working as a research fellow in the Department of Radiation Oncology at the University of Massachusetts Medical School. He remained in this position until 2016, before moving to Harvard T.H. Chan School of Public Health as a resident physician. Michael would end up excelling in his role as a resident, landing him a position as the chief resident physician, where he remains today. While Michael was a resident physician, he completed his Master of Public Health Harvard T.H. Chan School of Public Health. In August 2018, Michael expanded his professional portfolio with his position as an assistant professor at Vanderbilt University, and remains there currently.